Transketolase (TKT) is a crucial enzyme in the non-oxidative branch of the pentose phosphate pathway (PPP), catalyzing the transfer of two-carbon units between various sugar phosphates. This enzyme connects glycolysis to the pentose phosphate pathway, enabling cells to generate ribose-5-phosphate for nucleotide biosynthesis while also producing NADPH for antioxidant systems. TKT dysfunction has been strongly implicated in Alzheimer's disease (AD) and other neurodegenerative conditions, making it a significant therapeutic target.
TKT is a 623-amino acid homodimeric enzyme requiring thiamine pyrophosphate (TPP) as an essential cofactor. The enzyme catalyzes two reversible reactions: sedoheptulose-7-phosphate + glyceraldehyde-3-phosphate ⇌ erythrose-4-phosphate + fructose-6-phosphate, and ribose-5-phosphate + glyceraldehyde-3-phosphate ⇌ sedoheptulose-7-phosphate + fructose-6-phosphate. These reactions allow flexible redirection of carbon flux between glycolysis and nucleotide synthesis.
| Attribute |
Value |
| Protein Name |
Transketolase |
| Gene |
TKT |
| UniProt ID |
P29597 |
| PDB ID |
1R2J |
| Molecular Weight |
~70 kDa (per subunit) |
| Subcellular Location |
Cytoplasm |
| Protein Family |
Transketolase family |
| Cofactor |
Thiamine pyrophosphate (TPP) |
| Structure |
Homodimer |
| EC Number |
2.2.1.1 |
¶ Structure and Mechanism
¶ Domain Architecture
- N-terminal domain: Dimerization interface
- C-terminal domain: TPP binding and catalytic site
- Active site: Contains conserved residues for TPP stabilization
- TPP activation: TPP forms ylide intermediate in active site
- Aldehyde transfer: Accepts two-carbon unit from donor ketose
- Isomerization: Intermediate rearranges within active site
- Product release: Transfers two-carbon unit to acceptor aldose
TKT is highly sensitive to thiamine (vitamin B1) status:
- TPP cofactor required for all catalytic activity
- Thiamine deficiency directly impairs TKT function
- Provides biochemical basis for thiamine supplementation therapy
- Non-oxidative branch: Interconverts sugar phosphates
- Ribose-5-phosphate synthesis: Precursor for nucleotide biosynthesis
- NADPH generation: Supports antioxidant defenses and biosynthetic reactions
- Glycolysis-PPP bridge: Enables flexible carbon allocation
- Nucleotide biosynthesis: Provides ribose-5-phosphate for DNA/RNA
- NADPH production: Powers antioxidant systems (glutathione reductase)
- Neuronal metabolism: High energy demand requires robust PPP
- Myelin synthesis: PPP supports lipid biosynthesis for myelin
- Neurotransmitter synthesis: Ribose-5-phosphate for nucleotide pools
TKT dysfunction in AD is well-documented:
- Reduced activity: TKT activity significantly decreased in AD brain
- Thiamine deficiency: AD patients often show impaired thiamine metabolism
- Glucose hypometabolism: PPP dysfunction contributes to neuronal energy crisis
- Amyloid relationship: Aβ may directly inhibit TKT activity
- Therapeutic target: Thiamine supplementation shows cognitive benefits in some trials
Direct involvement due to thiamine deficiency:
- Thiamine-dependent: TKT highly sensitive to thiamine levels
- Memory impairment: Classic syndrome includes severe memory deficits
- Neuropathology: Mammillary body lesions in Wernicke's encephalopathy
Potential TKT connections:
- Energy metabolism: PD neurons show metabolic dysfunction
- NADPH需求: Antioxidant systems require NADPH
- Therapeutic potential: Thiamine may support neuronal function
- Diabetic neuropathy: Thiamine deficiency common in diabetes
- Peripheral neuropathy: TKT dysfunction may contribute
- Cognitive aging: Age-related decline in thiamine metabolism
- High-dose thiamine: Tested in AD and diabetic neuropathy
- Benfotiamine: Lipid-soluble thiamine derivative shows promise
- TPP administration: Direct cofactor supplementation
- PPP enhancers: Targeting PPP enzymes for neuroprotection
- NADPH boosters: Supporting antioxidant capacity
- Energy metabolism: Improving neuronal bioenergetics
TKT interacts with:
- Thiamine pyrophosphate (TPP) (cofactor)
- Glyceraldehyde-3-phosphate (substrate)
- Fructose-6-phosphate (substrate)
- Sedoheptulose-7-phosphate (substrate)
- Erythrose-4-phosphate (substrate)
- Ribose-5-phosphate (product)
- Glucose-6-phosphate dehydrogenase (PPP pathway)
- 6-Phosphogluconate dehydrogenase (PPP pathway)
The study of Tkt Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Martin, M.A., et al. (2013). Transketolase activity in peripheral blood mononuclear cells from patients with Alzheimer's disease. J Alzheimer's Dis, 37(1), 177-183. PMID:23803211
- Gibson, G.E., et al. (2013). Abnormal thiamine-dependent processes in Alzheimer's disease. Neurobiol Aging, 35(4), 878-885. PMID:24315776
- Mastroberardino, P.G., et al. (2009). Thiamine deficiency and oxidative stress in neurodegeneration. J Neural Transm, 116(11), 1449-1458. PMID:19705452
- Gibson, G.E., & Blass, J.P. (2007). Thiamine-dependent processes and the treatment of Alzheimer's disease. J Nutr Health Aging, 11(1), 32-33. PMID:17315077
- Baltrusch, S. (2021). The role of thiamine in the pathogenesis and progression of Alzheimer's disease. Int J Mol Sci, 22(13), 6849. PMID:34202865
- Zhao, Y., et al. (2012). Benfotiamine attenuates amyloid-β-induced toxicity in primary rat cortical neurons. Neurosci Lett, 516(1), 44-49. PMID:22472250